Literature DB >> 2294058

Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model.

A Kimura1, K T Mountzouros, D A Relman, S Falkow, J L Cowell.   

Abstract

Filamentous hemagglutinin (FHA) is a cell surface protein of Bordetella pertussis which functions as an adhesin for this organism. It is a component of many new acellular pertussis vaccines. The proposed role of FHA in immunity to pertussis is based on animal studies which have produced some conflicting results. To clarify this situation, we reexamined the protective activity of FHA in an adult mouse respiratory infection model. Four-week-old BALB/c mice were immunized with one or two doses of 4 or 8 micrograms of FHA and then aerosol challenged with B. pertussis Tohama I. In control mice receiving tetanus toxoid, the CFU in the lungs increased from 10(5) immediately following infection to greater than 10(6) by days 5 and 9 after challenge. Mice immunized with FHA by the intraperitoneal or intramuscular route had significantly reduced bacterial colonization in the lungs. A decrease in colonization of the trachea was also observed in FHA-immunized mice. Evaluation of antibody responses in these mice revealed high titers of immunoglobulin G (IgG) and IgM to FHA in sera and of IgG to FHA in lung lavage fluids. No IgA to FHA was detected. BALB/c mice were also passively immunized intravenously with either goat or rat antibodies to FHA and then aerosol challenged 24 h later, when anti-FHA antibodies were detected in the respiratory tract. Lung and tracheal colonization was markedly reduced in mice immunized with FHA-specific antibodies compared with those receiving control antibodies. In additional studies, the role of FHA in the colonization of the mouse respiratory tract was evaluated by using strain BP101, an FHA mutant of B. pertussis. FHA was important in the initial colonization of the mouse trachea, but was not required for colonization of the trachea later in the infection. FHA was not a factor in colonization of the lungs. Collectively, these experiments demonstrate (i) that systemic immunization with FHA can provide significant protection against B. pertussis infection in both the lower and upper respiratory tract of mice as defined by the lungs and trachea, respectively; (ii) that this protection is mediated primarily by serum antibodies to FHA, which transudate into respiratory secretions; and (iii) that FHA is an important upper respiratory tract colonization factor. These studies provide further evidence for the role of FHA in pertussis pathogenesis and immunity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2294058      PMCID: PMC258400          DOI: 10.1128/iai.58.1.7-16.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Development of a pertussis component vaccine in Japan.

Authors:  Y Sato; M Kimura; H Fukumi
Journal:  Lancet       Date:  1984-01-21       Impact factor: 79.321

2.  Heterogeneity of the filamentous haemagglutinin of Bordetella pertussis studied with monoclonal antibodies.

Authors:  L I Irons; L A Ashworth; P Wilton-Smith
Journal:  J Gen Microbiol       Date:  1983-09

3.  Tn5-induced mutations affecting virulence factors of Bordetella pertussis.

Authors:  A A Weiss; E L Hewlett; G A Myers; S Falkow
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

4.  Separation and purification of the hemagglutinins from Bordetella pertussis.

Authors:  Y Sato; J L Cowell; H Sato; D G Burstyn; C R Manclark
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

5.  Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin.

Authors:  E L Hewlett; K T Sauer; G A Myers; J L Cowell; R L Guerrant
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

6.  Identification of the predominant substrate for ADP-ribosylation by islet activating protein.

Authors:  G M Bokoch; T Katada; J K Northup; E L Hewlett; A G Gilman
Journal:  J Biol Chem       Date:  1983-02-25       Impact factor: 5.157

7.  Scanning electron microscopy of mouse ciliated oviduct and tracheal epithelium infected in vitro with Bordetella pertussis.

Authors:  L B Opremcak; M S Rheins
Journal:  Can J Microbiol       Date:  1983-04       Impact factor: 2.419

8.  Proliferative response of immune mouse T-lymphocytes to the lymphocytosis-promoting factor of Bordetella pertussis.

Authors:  F Fish; J L Cowell; C R Manclark
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

9.  A role of the B-oligomer moiety of islet-activating protein, pertussis toxin, in development of the biological effects on intact cells.

Authors:  M Tamura; K Nogimori; M Yajima; K Ase; M Ui
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157

10.  Effect of heptakis (2,6-O-dimethyl) beta-cyclodextrin on the production of pertussis toxin by Bordetella pertussis.

Authors:  A Imaizumi; Y Suzuki; S Ono; H Sato; Y Sato
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

View more
  64 in total

1.  Differential regulation of Bvg-activated virulence factors plays a role in Bordetella pertussis pathogenicity.

Authors:  S M Kinnear; R R Marques; N H Carbonetti
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract.

Authors:  B M van den Berg; H Beekhuizen; R J Willems; F R Mooi; R van Furth
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

3.  Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis.

Authors:  J W Petersen; P H Ibsen; K Hasløv; I Heron
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

4.  Group G streptococcal M protein exhibits structural features analogous to those of class I M protein of group A streptococci.

Authors:  C M Collins; A Kimura; A L Bisno
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

Review 5.  Virulence determinants involved in differential host niche adaptation of Neisseria meningitidis and Neisseria gonorrhoeae.

Authors:  Stephanie Schielke; Matthias Frosch; Oliver Kurzai
Journal:  Med Microbiol Immunol       Date:  2010-04-09       Impact factor: 3.402

6.  Identification of subregions of Bordetella pertussis filamentous hemagglutinin that stimulate human T-cell responses.

Authors:  A Di Tommaso; M Domenighini; M Bugnoli; A Tagliabue; R Rappuoli; M T De Magistris
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

7.  Characterization of vir-activated TnphoA gene fusions in Bordetella pertussis.

Authors:  T M Finn; R Shahin; J J Mekalanos
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

8.  A functional two-partner secretion system contributes to adhesion of Neisseria meningitidis to epithelial cells.

Authors:  Corinna Schmitt; David Turner; Maria Boesl; Marion Abele; Matthias Frosch; Oliver Kurzai
Journal:  J Bacteriol       Date:  2007-09-14       Impact factor: 3.490

9.  Cloning, expression, and DNA sequence analysis of genes encoding nontypeable Haemophilus influenzae high-molecular-weight surface-exposed proteins related to filamentous hemagglutinin of Bordetella pertussis.

Authors:  S J Barenkamp; E Leininger
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

10.  Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection.

Authors:  R D Shahin; D F Amsbaugh; M F Leef
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.